1 |
Adams, J. M. and Cory, S. (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 26, 1324-1337.
DOI
ScienceOn
|
2 |
Andrzejewski, T., Deeb, D., Gao, X., Danyluk, A., Arbab, A. S., Dulchavsky, S. A. and Gautam, S. C. (2008) Therapeutic effi cacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer. Oncol. Res. 17, 257-267.
DOI
ScienceOn
|
3 |
Armeanu, S., Lauer, U. M., Smirnow, I., Schenk, M., Weiss, T. S., Gregor, M. and Bitzer, M. (2003) Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Cancer Res. 63, 2369-2372.
|
4 |
Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang, L., McMurtrey, A. E., Hebert, A., DeForge, L., Koumenis, I. L., Lewis, D., Harris, L., Bussiere, J., Koeppen, H., Shahrokh, Z. and Schwall, R. H. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155-162.
DOI
ScienceOn
|
5 |
Bhojani, M. S., Rossú, B. D. and Rehemtulla, A. (2003) TRAIL and anti-tumor responses. Cancer Biol. Ther. 2 (4 Suppl 1), S71-S78.
|
6 |
Birt, D. F., Mitchell, D., Gold, B., Pour, P. and Pinch, H. C. (1997) Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer. Res. 17, 85-91.
|
7 |
Chiang, L. C., Ng, L. T., Lin, I. C., Kuo, P. L. and Lin, C. C. (2006) Antiproliferative effect of apigenin and its apoptotic induction in human Hep G2 cells. Cancer Lett. 237, 207-214.
DOI
ScienceOn
|
8 |
Cohen, G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16.
|
9 |
Deeb, D., Jiang, H., Gao, X., Hafner, M. S, Wong, H., Divine, G., Chapman, R. A., Dulchavsky, S. A. and Gautam, S. C. (2004) Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-through suppression of I phosphorylation. Mol. Cancer Ther. 3, 803-812.
|
10 |
Eggert, A., Grotzer, M. A., Zuzak, T. J., Wiewrodt, B. R., Ho, R., Ikegaki, N. and Brodeur, G. M. (2001) Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res. 61, 1314-1319.
|
11 |
Gross, A., McDonnell, J. M. and Korsmeyer, S. J. (1999) BCL-2 family members and the mitochondria in apoptosis. Genes. Dev. 13, 1899-1911.
DOI
ScienceOn
|
12 |
Gupta, S., Afaq, F. and Mukhtar, H. (2001) Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem. Biophys. Res. Commun. 287, 914-920.
DOI
ScienceOn
|
13 |
Hao, C., Song, J. H., Hsi, B., Lewis, J., Song, D. K., Petruk, K. C., Tyrrell, D. L. and Kneteman, N. M. (2004) TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice. Cancer Res. 64, 8502-8506.
DOI
ScienceOn
|
14 |
Higashitsuji, H., Higashitsuji, H., Masuda, T., Liu, Y., Itoh, K. and Fujita, J. (2007) Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1. J. Biol. Chem. 282, 13716-13725.
DOI
|
15 |
Hinz, S., Trauzold, A., Boenicke, L., Sandberg, C., Beckmann, S., Bayer, E., Walczak, H., Kalthoff, H. and Ungefroren, H. (2000) Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene. 19, 5477-5486.
DOI
ScienceOn
|
16 |
Jacquemin, G., Shirley, S. and Micheau, O. (2010) Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells? Cell Mol. Life Sci. 67, 3115-3130.
DOI
ScienceOn
|
17 |
Johnstone, R. W., Ruefl i, A. A. and Lowe, S. W. (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108, 153-164.
DOI
ScienceOn
|
18 |
Koschny, R., Ganten, T. M., Sykora, J., Haas, T. L., Sprick, M. R., Kolb, A., Stremmel, W. and Walczak, H. (2007) TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specifi c apoptosis within a therapeutic window. Hepatology. 45, 649-658.
DOI
ScienceOn
|
19 |
Jung, E. M., Lim, J. H., Lee, T. J., Park, J. W., Choi, K. S. and Kwon, T. K. (2005) Curcumin sensitizes tumor necrosis factor-related apoptosis- inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis. 26, 1905-1913.
DOI
ScienceOn
|
20 |
Kim, D. S., Jeong, Y. M., Moon, S. I., Kim, S. Y., Kwon, S. B., Park, E. S., Youn, S. W. and Park, K. C. (2006) Indole-3-carbinol enhances ultraviolet B-induced apoptosis by sensitizing human melanoma cells. Cell Mol. Life Sci. 63, 2661-2668.
DOI
ScienceOn
|
21 |
Kruyt, F. A. (2008) TRAIL and cancer therapy. Cancer Lett. 263, 14-25.
DOI
ScienceOn
|
22 |
Lawrence, D., Shahrokh, Z., Marsters, S., Achilles K,, Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., Hooley, J., Sherwood, S., Pai, R., Leung, S., Khan, L., Gliniak, B., Bussiere, J., Smith, C. A., Strom, S. S., Kelley, S., Fox, J. A., Thomas, D. and Ashkenazi, A. (2001) Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat. Med. 7, 383-385.
DOI
ScienceOn
|
23 |
Moll, U. M. and Zaika, A. (2001) Nuclear and mitochondrial apoptotic pathways of p53. FEBS. Lett. 493, 65-69.
DOI
ScienceOn
|
24 |
Nitsch, R., Bechmann, I., Deisz, R. A., Haas, D., Lehmann, T. N., Wendling, U., and Zipp, F. (2000) Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet. 356, 827-828.
DOI
ScienceOn
|
25 |
Roth, W., Isenmann, S., Naumann, U., Kugler, S., Bähr, M., Dichgans, J., Ashkenazi, A. and Weller, M. (1999) Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem. Biophys. Res. Commun. 265, 479-483.
DOI
ScienceOn
|
26 |
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffi th, T.S., Kubin, M., Chin, W., Jones J, Woodward, A., Le, T., Smith, C., Smolak, P., Goodwin, R. G., Rauch, C. T., Schuh J, C. and Lynch, D. H. (1999) Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5, 157-163.
DOI
ScienceOn
|
27 |
Siegelin, M. D., Reuss, D. E., Habel, A., Herold-Mende, C. and von Deimling, A. (2008) The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin. Mol. Cancer Ther. 7, 3566-3574.
DOI
ScienceOn
|
28 |
Sun, X. M., MacFarlane, M., Zhuang, J., Wolf, B. B., Green, D. R. and Cohen, G. M. (1999) Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274, 5053-5060.
DOI
ScienceOn
|
29 |
Van Geelen, C. M., de Vries, E. G. and de Jong, S. (2004) Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resist. Updat. 7, 345-358.
DOI
ScienceOn
|
30 |
Wang, W., Heideman, L., Chung, C. S., Pelling, J. C., Koehler, K. J. and Birt, D. F. (2000) Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol. Carcinog. 28, 102-110.
DOI
ScienceOn
|
31 |
Way, T. D., Kao, M. C. and Lin, J. K. (2003) Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neuoverexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 279, 4479-4489.
DOI
|
32 |
Wei, H., Tye, L., Bresnick, E. and Birt, D. F. (1990) Inhibitory effect of apigenin, a plant fl avonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res. 50, 499-502.
|
33 |
Wolf, B. B. and Green, D. R. (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J. Biol. Chem. 274, 20049-20052.
DOI
|
34 |
Zhang, Y. and Zhang, B. (2008) TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Mol. Cancer Res. 6, 1861-1871.
DOI
ScienceOn
|
35 |
Yano, Y., Hayashi, Y., Nakaji, M., Nagano, H., Seo, Y., Ninomiya, T., Yoon, S., Wada, A., Hirai, M., Kim, S. R., Yokozaki, H. and Kasuga, M. (2003) Different apoptotic regulation of TRAIL-caspase pathway in HBV- and HCV-related hepatocellular carcinoma. Int. J. Mol. Med. 11, 499-504.
|
36 |
Yoshida, T., Konishi, M., Horinaka, M., Yasuda, T., Goda, A. E., Taniguchi, H., Yano, K., Wakada, M. and Sakai, T. (2008) Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem. Biophys. Res. Commun. 375, 129-133.
DOI
ScienceOn
|
37 |
Zhang, L. and Fang, B. (2005) Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 12, 228-237.
DOI
ScienceOn
|